Cite
APA Citation
Viola, D., Cappagli, V., & Elisei, R. (2013). cabozantinib (XL184) for the treatment of locally advanced or metastatic progressive medullary thyroid cancer. Future oncology, 9, 1083–1092. http://access.bl.uk/ark:/81055/vdc_100136004237.0x00003b